Sargent Investment Group, LLC

Position in NAGE — Niagen Bioscience, Inc.

CIK 1766157 BETHESDA, MD

Position in NAGE

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$66,150

-$29,250 QoQ

Shares Held

15,000

0.0% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Sargent Investment Group, LLC holds $8,795,985 across 5 Biotechnology names. NAGE ranks #4 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	179,025	$7,678,382
2	MDWD	MediWound Ltd.	59,481	$958,238
3	ARDX	Ardelyx, Inc.	14,500	$86,855
4	NAGE	Niagen Bioscience, Inc. This page	15,000	$66,150
5	MTNB	Matinas BioPharma Holdings, Inc.	12,720	$6,360

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$66,150	15,000	0.0%	Shares	Sole	2026-05-11
2025-12-31	$95,400	15,000	-57.1%	Shares	Sole	2026-02-13
2025-09-30	$326,568	35,002	-30.0%	Shares	Sole	2025-11-14
2025-06-30	$720,500	50,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$345,000	50,000	0.0%	Shares	Sole	2025-05-05
2024-12-31	$265,500	50,000	+212.5%	Shares	Sole	2025-01-27
2022-06-30	$26,720	16,000	0.0%	Shares	Sole	2022-07-26
2022-03-31	$39,360	16,000	0.0%	Shares	Sole	2022-05-06
2021-12-31	$59,840	16,000	-23.8%	Shares	Sole	2022-02-11
2021-09-30	$131,670	21,000	+5.0%	Shares	Sole	2021-11-12
2021-06-30	$197,200	20,000	0.0%	Shares	Sole	2021-08-05
2021-03-31	$186,800	20,000	0.0%	Shares	Sole	2021-05-04
2020-12-31	$96,000	20,000	-20.0%	Shares	Sole	2021-02-10
2020-09-30	$100,250	25,000	+108.3%	Shares	Sole	2020-11-12
2020-06-30	$55,080	12,000	-87.2%	Shares	Sole	2020-08-11
2020-03-31	$306,440	94,000	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.